POSA68 Cost Minimization Analysis of Fixed-Dose Triple Therapy with Budesonide/Glycopyrronium/Formoterol Fumarate Versus Open Triple Therapy for Moderate-to-Very Severe COPD in the United Kingdom
Abstract
Authors
E de Nigris U Holmgren C Treharne N Brighton A Walker J Haughney